Viewing Study NCT06411457


Ignite Creation Date: 2025-12-24 @ 6:34 PM
Ignite Modification Date: 2026-02-27 @ 10:37 AM
Study NCT ID: NCT06411457
Status: RECRUITING
Last Update Posted: 2024-05-17
First Post: 2024-05-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module